Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults

Inclusion Criteria: * Healthy adult males or females age ≥18 years of age with signed informed consent. * Women who are not post-menopausal or surgically sterile must have a negative serum pregnancy test at screening and within 24 hours of treatment and who agree to use effective contraception for 30 days following the study. Exclusion Criteria: * Clinically significant laboratory abnormalities, * Clinically significant abnormalities on physical examination, * BMI of less than 18 kg/m2 or greater than 32 kg/m2, * Any disease or condition that might compromise the cardiovascular, hematological, renal, hepatic, pulmonary (including chronic asthma), endocrine (e.g., diabetes), central nervous, or gastrointestinal (including an ulcer) systems, * History of seizures or epilepsy, * History of serious mental illness, * Participant in unrelated research involving investigational product within 30 days before planned date of drug administration, * Positive serology for HIV 1, HIV 2, HBsAg, or HCV, * Fever greater than 37.5°C at the time of planned dosing, * Suspicion of or recent history of alcohol or substance abuse, * Donated blood or blood products within the past 30 days, * Women who are pregnant or breastfeeding, * Employee or family member of the investigational site, and * Subjects who currently smoke cigarettes, cigars, pipes or chew tobacco products, * Subjects who are either unwilling to agree to refrain from use or found to be using: 1. Alcohol, caffeine, xanthine-containing food or beverages, nicotine products and over-the-counter medications with the exception of Tylenol from 24 hours prior to dosing and throughout the confinement period 2. Prescription medications from 14 days prior to and 7 days post treatment 3. Oral contraceptives without concomitant use of double-barrier contraceptives (condom, diaphragm with spermicide) for a period of 7 days prior to and 30 days post treatment